Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health
Bear Case

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

• Corporate insiders have been selling shares recently, with CEO Deborah Weitzman selling 7,354 shares and CAO Mary C. Scherer selling 2,302 shares in August 2026, which may signal that company leadership is taking advantage of higher stock prices to reduce their personal exposure.
• The company's net margin is only 0.67% and it reported a negative return on equity of 98.53% in the most recent quarter, indicating that while revenue is growing, the company is struggling to convert that top-line growth into substantial bottom-line profitability and efficient use of shareholder capital.
• Cardinal Health, Inc. faces regulatory risks from Inflation Reduction Act (IRA) pricing changes, which management expects will pressure pharmaceutical revenues, potentially impacting the company's ability to maintain its current margin levels despite efforts to protect profitability through distribution agreements.
• Short interest in the stock has fluctuated, with shares shorted reaching 6,668,906 as of September 15, 2026, and days to cover at 4.58, suggesting that a portion of the market remains skeptical about the stock's valuation or future performance despite recent earnings beats.
• Revenue for the most recent quarter was $63.67 billion, which missed the consensus estimate of $65.15 billion, indicating that while earnings were strong, the company may be facing headwinds in its core distribution business that could limit future top-line growth.